Free Trial

Unicycive Therapeutics (UNCY) Earnings Date, Estimates & Call Transcripts

$1.00
-0.04 (-3.83%)
(As of 05/22/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 12Estimated
Actual EPS
(Mar. 28)
-$0.16 Beat By $0.02
Consensus EPS
(Mar. 28)
-$0.18
Skip Charts & View Estimated and Actual Earnings Data

UNCY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

UNCY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Unicycive Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.18)($0.18)($0.18)
Q2 20241($0.21)($0.21)($0.21)
Q3 20241($0.17)($0.17)($0.17)
Q4 20241($0.16)($0.16)($0.16)
FY 20244($0.72)($0.72)($0.72)

UNCY Earnings Date and Information

Unicycive Therapeutics last issued its earnings data on March 28th, 2024. The reported ($0.16) EPS for the quarter, topping analysts' consensus estimates of ($0.18) by $0.02. Unicycive Therapeutics has generated ($1.19) earnings per share over the last year (($1.19) diluted earnings per share). Earnings for Unicycive Therapeutics are expected to grow in the coming year, from ($0.47) to ($0.38) per share. Unicycive Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off prior year's report dates.

Unicycive Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/12/2024
(Estimated)
------- 
3/28/2024Q4 2023($0.18)($0.16)+$0.02($0.16)--
11/14/2023Q3 2023($0.13)($0.13)-($0.13)--
8/14/2023Q2 2023($0.39)($0.29)+$0.10($0.29)--
5/16/2023Q1 2023($0.36)($0.29)+$0.07$0.39$0.75 million$0.68 million
3/31/2023Q4 2022-($0.35)($0.35)($0.35)--
11/14/2022Q3 2022($0.35)($0.37)($0.02)($0.37)-$0.95 million
8/15/2022Q2 2022($0.27)($0.24)+$0.03($0.24)--
5/12/2022Q1 2022($0.20)($0.24)($0.04)($0.24)--    
3/31/2022Q4 2021-($0.17)($0.17)($0.17)--
11/11/2021Q3 2021($0.11)($0.37)($0.26)($0.37)--
8/16/2021Q2 2021($0.11)($0.13)($0.02)($0.13)--

Unicycive Therapeutics Earnings - Frequently Asked Questions

When is Unicycive Therapeutics's earnings date?

Unicycive Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates. Learn more on UNCY's earnings history.

Did Unicycive Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Unicycive Therapeutics (NASDAQ:UNCY) reported ($0.16) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.18) by $0.02. Learn more on analysts' earnings estimate vs. UNCY's actual earnings.

How much revenue does Unicycive Therapeutics generate each year?

Unicycive Therapeutics (NASDAQ:UNCY) has a recorded annual revenue of $680,000.00.

How much profit does Unicycive Therapeutics generate each year?

Unicycive Therapeutics (NASDAQ:UNCY) has a recorded net income of -$30.54 million. UNCY has generated -$1.19 earnings per share over the last four quarters.

What is Unicycive Therapeutics's EPS forecast for next year?

Unicycive Therapeutics's earnings are expected to grow from ($0.47) per share to ($0.38) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:UNCY) was last updated on 5/22/2024 by MarketBeat.com Staff

From Our Partners